Aurora Spine
-
Financial
Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results
Company reports highest quarterly revenue in Company’s history of $4.1 million, 68% year over year increase and 15% sequential growth…
Read More » -
Regulatory
Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its ZIP™ series of MIS implants
CARLSBAD, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Regulatory
Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Technology For Motion Preservation or Fusion
CARLSBAD, Calif., June 13, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Spine
Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-L™ Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform
CARLSBAD, Calif, June 06, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Spine
Aurora Spine Corporation Announces Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
Dr. Sebastian Koga, Neurosurgeon completes the first surgeries using Aurora Spine’s DEXA-C patient matched implant CARLSBAD, Calif., March 03, 2022…
Read More » -
Spine
Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical
Aurora Spine’s DEXA Technology patient-matched implants supported by Echolight’s newest technologies in bone health assessment CARLSBAD, Calif., Feb. 24, 2022…
Read More » -
Financial
Aurora Spine Corporation Announces Preliminary Revenue for Fourth Quarter and Fiscal 2021
– Company experiencing improved sales momentum from proprietary products – CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Aurora Spine…
Read More » -
Spine
Aurora Spine Receives “Notice of Allowance” for Patent for Spinal Implant for Motion Preservation or Fusion
– New Patent will Strengthen Company’s IP Portfolio CARLSBAD, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora…
Read More » -
Spine
Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLO™ Cervical Plate
CARLSBAD, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Spine
Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Density-Matched Interbody Cage
CARLSBAD, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Spine
Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products
CARLSBAD, Calif. , Dec. 02, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB:…
Read More » -
Financial
Aurora Spine Corporation Announces Closing of C$6.5 Million Private Placement with Institutional Investors
CARLSBAD, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Financial
Aurora Spine Corporation Announces C$6.5 Million Private Placement with Institutional Investors
CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Spine
Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device
CARLSBAD, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
Regulatory
Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System
Product approval is the first in the world using Company’s proprietary and patented DEXA Technology™ for custom made implants based…
Read More »